Skip to content
2000
Volume 16, Issue 5
  • ISSN: 1573-4072
  • E-ISSN: 1875-6646

Abstract

Background: The objective of the research was to examine the DPPIV inhibitor activity of synthetic derivatives of 2-aminobenzimidazole derivatives by the in-vivo method. Methods: Molecular docking was performed using homology model of receptors to identify the binding sites for the inhibitory activity of diabetes by means of- CDocker energy using the Discovery Studio (DS) 4.5 Novel 2-amino benzimidazole derivatives were synthesized from orthophenylene diamine with cyanogens bromide. The synthesized compounds were identified by IR,1HNMR,13CNMR, and MASS spectroscopic techniques. The products were analyzed for their DPPIV inhibitory effects on Wistar Albino rat. Results: The results revealed that benzimidazole with para-aminobenzoic acid possesses best DPPIV inhibitor activity. 2- amino benzimidazole incorporated with aromatic compounds were synthesized and assessed for their DPP-IV inhibitor activity. Conclusion: 2- amino benzimidazole with para-aminobenzoic acid can be used as a lead compound for the development of a new class of DPP-IV inhibitor.

Loading

Article metrics loading...

/content/journals/cbc/10.2174/1573407215666190318121902
2020-06-01
2025-07-06
Loading full text...

Full text loading...

/content/journals/cbc/10.2174/1573407215666190318121902
Loading

  • Article Type:
    Research Article
Keyword(s): 2-amino benzimidazole; antihypertensive; docking; DPPIV inhibitor; sitagliptin; spectroscopy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test